Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 316 | 555 | 353 | 0 | 400 |
| Gross Profit | 316 | 555 | 353 | N/A | 400 |
| Operating Expenses | 2,122 | 2,155 | 5 | 0 | 1,262 |
| Operating Income | -1,806 | -1,600 | -5 | N/A | -862 |
| Interest Expense | 451 | 732 | 868 | 0 | 711 |
| Other Income | 0 | -78 | 868 | 0 | 3 |
| Pre-tax Income | -2,256 | -2,410 | -5 | 0 | -1,570 |
| Income Tax | N/A | 2 | N/A | N/A | 2 |
| Net Income Continuous | -2,256 | -2,411 | -5 | N/A | -1,572 |
| Net Income | $-2,256 | $-2,411 | $-5 | $N/A | $-1,572 |
| EPS Basic Total Ops | -4.50 | -6.61 | 0.00 | N/A | -9.01 |
| EPS Basic Continuous Ops | -4.45 | -6.52 | -0.03 | N/A | -9.01 |
| EPS Diluted Total Ops | -4.50 | -6.61 | 0.00 | N/A | -9.01 |
| EPS Diluted Continuous Ops | -4.45 | -6.52 | -0.03 | N/A | -9.01 |
| EBITDA(a) | $-1,522 | $-1,175 | $-1,088 | $N/A | $-370 |